Literature DB >> 27383814

Effect of Triclosan-Coated Suture and Antibiotic Prophylaxis on Infection and Recurrence after Karydakis Flap Repair for Pilonidal Disease: A Randomized Parallel-Arm Double-Blinded Clinical Trial.

Aziz Bora Karip1, Kafkas Çelik1, Timuçin Aydın1, Hanife Yazıcılar2, Yalın İşcan1, Canan Ağalar3, Kemal Memişoğlu1.   

Abstract

BACKGROUND: Pilonidal sinus disease was first described by Mayo in 1833 as "a cyst that contains hair." Although surgical treatment of the lesions can have successful outcomes, it also can be associated with relatively high rates of post-operative infectioins and recurrence. Many studies have demonstrated that triclosan-coated sutures (TCS) decrease surgical site infections.
OBJECTIVE: The goal of this randomized parallel-arm double-blind clinical trial was to investigate the ability of antibiotic prophylaxis, and secondarily of antibiotic-coated sutures, to prevent post-operative infections in the surgical management of pilonidal sinus disease. PATIENTS AND METHODS: The initial trial protocol aimed to compare early infections in patients who did and did not undergo antibiotic prophylaxis (AP(+) vs. AP(-)). A secondary goal was to compare the effects of TCS and conventional sutures (CS) on early infectious complication rates in the two groups. The AP(-) arm had to be terminated prematurely because of an unacceptably high rate of infectious complications.
RESULTS: A total of 80 micro-organisms were recovered from 74 patients (69.8%). Methicillin-susceptible coagulase-negative staphylococci were the most common isolates (30%). The most frequently detected anaerobic micro-organism was Actinomyces israelii (7.5%). The TCS and CS groups had similar rates of micro-organism growth (65.8% vs. 75.0%). There was no significant difference in the occurrence of wound dehiscence. Over the six-month follow-up, there were two recurrences, both in the TCS group. The difference was not significant.
CONCLUSIONS: We believe that antibiotic prophylaxis is necessary in patients scheduled for Karydakis flap repair. In our study, TCS tended to be associated with a lower rate of infection, but this trend did not achieve statistical significance. Anaerobic micro-organisms dominated the infective isolates.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27383814     DOI: 10.1089/sur.2015.207

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  6 in total

Review 1.  Management of sacrococcygeal pilonidal sinus disease.

Authors:  Rhiannon L Harries; Abdullah Alqallaf; Jared Torkington; Keith G Harding
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

2.  Effect of triclosan-coated sutures on surgical site infections in pilonidal disease: prospective randomized study.

Authors:  Naciye Cigdem Arslan; Gulsen Atasoy; Tansu Altintas; Cem Terzi
Journal:  Int J Colorectal Dis       Date:  2018-07-30       Impact factor: 2.571

3.  Pilonidal sinus disease recurrence at a tertiary care center in Riyadh.

Authors:  Ibrahim Tawfiq Albabtain; Abdullah Alkhaldi; Lama Aldosari; Lina Alsaadon
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

4.  Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence.

Authors:  V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

5.  The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature.

Authors:  Imran Ahmed; Adam Jonathan Boulton; Sana Rizvi; William Carlos; Edward Dickenson; N A Smith; Mike Reed
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

6.  Impact of geography and surgical approach on recurrence in global pilonidal sinus disease.

Authors:  Dietrich Doll; Andriu Orlik; Katharina Maier; Peter Kauf; Marco Schmid; Maja Diekmann; Andreas P Vogt; Verena K Stauffer; Markus M Luedi
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.